The Effect of the Parasite Toxoplasma gondii on the Mother and Fetus in Samples Taken from Hospitals in Mosul City

Raad A.  Abd-Algany

doi:10.51699/cajmns.v7i3.3329

Authors

Raad A. Abd-Algany Nineveh Education Directorate, Iraq

DOI:

https://doi.org/10.51699/cajmns.v7i3.3329

Keywords:

Toxoplasma gondii, cat, IgG and IgM, abortion, immunological markers

Abstract

The study revealed that Toxoplasma gondii is one of the most common parasites affecting pregnant women and leading to early or late miscarriage. Tests were conducted on 120 samples from participating women who visited public and private health institutions in Mosul. The study showed that 92 women exhibited symptoms of T. gondii infection. After performing serum tests, 74 participants tested positive for the parasite by identifying immunological markers (IgG and IgM). The prevalence of IgG antibodies was found to be 92.5% (IU/mL) in 50 identified samples, indicating latent or chronic infection. The prevalence of IgM antibodies in serum reached 57.1% (IU/mL) in 14 confirmed samples, indicating a recent and acute infection with T. gondii. Furthermore, 16 out of 24 samples showed both types of antibodies. Antibodies or immune markers, IgG and IgM, were found in 66.6% of women (IU/mL) with a standard deviation of ±2.32 and a p-value of <0.0001. The study also showed that contact with cats increases the infection rate, with 78.3% of women who do not live with cats having an infection rate of 21.7%. Furthermore, the number of previous abortions increases the infection and abortion rates by more than 66% compared to other cases, as does the consumption of contaminated food. This study also indicated that the 20-30 age group is 54% more susceptible to infection with the T. gondii parasite than other age groups. Additionally, women living in cities were found to be twice as likely to be infected as women living in rural areas. The study also found that women living in cities are more likely to be infected than women living in rural areas.

References

E. Watts, Y. Zhao, A. Dhara, B. Eller, A. Patwardhan, and A. P. Sinai, “Novel Approaches Reveal that Toxoplasma gondii Bradyzoites within Tissue Cysts Are Dynamic and Replicating Entities In Vivo,” mBio, vol. 6, no. 5, Art. no. e01155-15, 2015.

C. Konradt, N. Ueno, D. A. Christian, J. H. Delong, G. H. Pritchard, J. Herz, et al., “Endothelial cells are a replicative niche for entry of Toxoplasma gondii to the central nervous system,” Nature Microbiology, vol. 1, Art. no. 16001, 2016.

J. P. Dubey, “The history of Toxoplasma gondii—the first 100 years,” Journal of Eukaryotic Microbiology, vol. 55, no. 6, pp. 467–475, 2008.

S. Almeria and J. P. Dubey, “Foodborne transmission of Toxoplasma gondii infection in the last decade: An overview,” Research in Veterinary Science, vol. 135, pp. 371–385, 2021.

J. L. Jones, V. Dargelas, J. Roberts, C. Press, J. S. Remington, and J. G. Montoya, “Risk factors for Toxoplasma gondii infection in the United States,” Clinical Infectious Diseases, vol. 49, no. 6, pp. 878–884, 2009.

Q. Liu, Z.-D. Wang, S.-Y. Huang, and X.-Q. Zhu, “Diagnosis of toxoplasmosis and typing of Toxoplasma gondii,” Parasites & Vectors, vol. 8, Art. no. 292, 2015.

T. S. Lima and M. B. Lodoen, “Mechanisms of Human Innate Immune Evasion by Toxoplasma gondii,” Frontiers in Cellular and Infection Microbiology, vol. 9, Art. no. 103, 2019.

C. Rudin, H. H. Hirsch, R. Spaelti, S. Schaedelin, and T. Klimkait, “Decline of Seroprevalence and Incidence of Congenital Toxoplasmosis Despite Changing Prevention Policy—Three Decades of Cord-Blood Screening in Northwestern Switzerland,” Pediatric Infectious Disease Journal, vol. 37, no. 11, pp. 1087–1092, 2018.

Y. Zhang, B. S. Lai, M. Juhas, and Y. Zhang, “Toxoplasma gondii secretory proteins and their role in invasion and pathogenesis,” Microbiological Research, vol. 227, Art. no. 126293, 2019.

F. Peyron, C. L’ollivier, L. Mandelbrot, M. Wallon, R. Piarroux, F. Kieffer, et al., “Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group,” Pathogens, vol. 8, no. 1, Art. no. 24, 2019.

A. A. H. Al-Awadi, R. Abdul Ghani, and A. M. Al-Mekhlafi, “Toxoplasma gondii Infection Among Institutionalized Children with Down Syndrome in Sana'a City, Yemen: Implications of Low IgG Seroprevalence,” Acta Parasitologica, vol. 67, no. 1, pp. 530–534, 2022.

F. Kheirandish, B. Ezatpour, S. Fallahi, M. J. Tarahi, P. Hosseini, A. K. Rouzbahani, et al., “Toxoplasma serology status and risk of miscarriage: A case-control study among women with a history of spontaneous abortion,” International Journal of Fertility & Sterility, vol. 13, no. 3, pp. 184–189, 2019.

L. Gras, R. E. Gilbert, M. Wallon, F. Peyron, and M. Cortina-Borja, “Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: Implications for clinical practice and cross-sectional incidence studies,” Epidemiology and Infection, vol. 132, no. 3, pp. 541–548, 2004.

S. Cassaing, et al., “Comparison between Two Amplification Sets for Molecular Diagnosis of Toxoplasmosis by Real-Time PCR,” Journal of Clinical Microbiology, vol. 44, no. 3, pp. 720–724, 2006.

H. Yamada, et al., “A cohort study of maternal screening for congenital Toxoplasma gondii infection: 12 years’ experience,” Journal of Infection and Chemotherapy, vol. 25, no. 6, pp. 427–430, 2019.

R. Ahmadi, J. Sadeghinasab, A. Siyadatpanah, F. Mirzaei, B. Aghcheli, and R. Norouzi, “Frequency of Toxoplasma gondii, Rubella, and Cytomegalovirus Antibodies in Pregnant Women in Yazd Province, Iran,” Advanced Journal of Clinical Microbiology and Infection, vol. 10, no. 4, pp. 145–151, 2023.

M. Teweldemedhin, A. Gebremichael, G. Geberkirstos, H. Hadush, T. Gebrewahid, S. W. Asgedom, et al., “Seroprevalence and Risk Factors of Toxoplasma gondii Among Pregnant Women in Adwa District, Northern Ethiopia,” BMC Infectious Diseases, vol. 19, no. 1, Art. no. 327, 2019.

M. Marangi, N. Lago, G. Mancinelli, O. L. Antonio, T. Scirocco, M. Sinigaglia, et al., “Occurrence of the protozoan parasites Toxoplasma gondii and Cyclospora cayetanensis in the invasive Atlantic blue crab Callinectes sapidus from the Lesina Lagoon (SE Italy),” Marine Pollution Bulletin, vol. 176, Art. no. 113428, 2022.

N. Nazari, A. Bozorgomid, A. Janbakhsh, and F. Bashiri, “Toxoplasma gondii and human immunodeficiency virus co-infection in western Iran: A cross-sectional study,” Asian Pacific Journal of Tropical Medicine, vol. 11, no. 1, pp. 58–62, 2018.

Z. Zhou, H. I. A. Lopez, G. E. Pérez, L. M. Burgos, J. M. Farina, C. Saldarriaga, et al., “Toxoplasmosis and the Heart,” Current Problems in Cardiology, vol. 46, no. 3, Art. no. 100741, 2021.

P. O. Odeniran, K. F. Omolabi, and I. O. Ademola, “Risk factors associated with seropositivity for Toxoplasma gondii in population-based studies among immunocompromised patients in West African countries, Cameroon and Gabon: A meta-analysis,” Acta Tropica, vol. 209, Art. no. 105544, 2020.

B. Achaw, H. Tesfa, A. J. Zeleke, L. Worku, A. Addisu, N. Yigzaw, et al., “Sero-prevalence of Toxoplasma gondii and associated risk factors among psychiatric outpatients attending University of Gondar Hospital, Northwest Ethiopia,” BMC Infectious Diseases, vol. 19, no. 1, pp. 1–8, 2019.

E. Watts, Y. Zhao, A. Dhara, B. Eller, A. Patwardhan, and A. P. Sinai, “Novel Approaches Reveal that Toxoplasma gondii Bradyzoites within Tissue Cysts Are Dynamic and Replicating Entities In Vivo,” mBio, vol. 6, no. 5, Art. no. e01155-15, 2015.

S. Shojaee, A. Teimouri, H. Keshavarz, S. J. Azami, and S. Nouri, “The relation of secondary sex ratio and miscarriage history with Toxoplasma gondii infection,” BMC Infectious Diseases, vol. 18, no. 1, Art. no. 307, 2018.